Autoradiographic mapping of a selective cyclic adenosine monophosphate phosphodiesterase in rat brain with the antidepressant [3H]rolipram

Rolipram is a clinically effective antidepressant with selective cAMP phosphodiesterase (PDE) inhibiting properties. (+/-)-[3H]Rolipram binds with high affinity (Kd = 2.52 +/- 0.47 nM) to sections of rat brain (Hill number = 0.90 +/- 0.05). Binding is stereospecific. Association of (+/-) [3H]rolipram to sections is rapid (47% of specific binding in the first minute, kobs = 0.52 min-1). Dissociation of (+/-)-[3H]rolipram exhibits non first order kinetics (3 component model; t1/2 = 2.5 min, 50 min and 6 h, respectively). A number of PDE inhibitors reduce (+/-)-[3H]rolipram binding to the level of nonspecific binding ((-)-rolipram, IC50 = 0.9 nM; (+/-)-rolipram, IC50 = 1.5 nM; Ro 20-1724, IC50 = 11 nM; ICI 63.197, IC50 = 35 nM; medazepam, IC50 = 240 nM; diazepam, IC50 = 1200 nM; IBMX, IC50 = 3800 nM). In vitro autoradiography reveals high binding site densities in the cerebellum, olfactory bulb, lateral septal nucleus, frontal cortex, subiculum and CA1 of hippocampus. Most of the labeled structures are part of the limbic system. In vivo autoradiography of (+/-)-[3H]rolipram binding shows much more nonspecific binding than in vitro, nevertheless the distribution pattern of (+/-)-[3H]rolipram binding sites is similar. A comparison of the distribution pattern of (+/-)-[3H]rolipram binding sites with that of an antidepressant (monoamine oxidase inhibitor, monoamine uptake inhibitor) reveals no overlap. Limited, though significant correlations exist with the distribution of beta 1-adrenergic, adenosine1 and glutamate/quisqualate receptors as well as protein kinase C, but not with beta 2-adrenergic receptors and forskolin binding sites.

[1]  P. Willner.  Validation criteria for animal models of human mental disorders: Learned helplessness as a paradigm case , 1986, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[2]  J. Nadler,et al.  Perforant path lesion depletes glutamate content of fascia dentata synaptosomes , 1981, Neuroscience Letters.

[3]  B. Pflug,et al.  Results of a Phase II Study of the Antidepressant Effect of Rolipram , 1984, Pharmacopsychiatry.

[4]  M. Herkenham,et al.  Mismatches between neurotransmitter and receptor localizations in brain: observations and implications , 1987, Neuroscience.

[5]  H. Wachtel,et al.  Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors , 1986, Neuropharmacology.

[6]  G. Pahlke,et al.  Sensitivity of a cAMP PDE to Rolipram in Different Organs , 1987 .

[7]  M. Cuénod,et al.  Selective retrograde transport of d-aspartate in spinal interneurons and cortical neurons of rats , 1982, Brain Research.

[8]  M. Reddington,et al.  Autoradiographic evidence for multiple CNS binding sites for adenosine derivatives , 1986, Neuroscience.

[9]  A. Biegon,et al.  Localization and characterization of [3H]desmethylimipramine binding sites in rat brain by quantitative autoradiography , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[10]  B. Ilien,et al.  Pharmacological inhibition of calmodulin-sensitive phosphodiesterases. , 1982, Journal de pharmacologie.

[11]  H. Korr.  Light Microscopical Autoradiography of Nervous Tissue , 1981 .

[12]  S. Snyder,et al.  Heterogeneous localization of protein kinase C in rat brain: autoradiographic analysis of phorbol ester receptor binding , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[13]  G. Brüning,et al.  Characterization and quantitative autoradiography of [3H]tryptamine binding sites in rat brain , 1986, Brain Research.

[14]  J. Penney,et al.  Quantitative autoradiographic distribution of L-[3H]glutamate-binding sites in rat central nervous system , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  J. Daly,et al.  4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain. , 1976, Molecular pharmacology.

[16]  H. Schneider.  Brain cAMP response to phosphodiesterase inhibitors in rats killed by microwave irradiation or decapitation. , 1984, Biochemical pharmacology.

[17]  C. Davis,et al.  Assessment of selective inhibition of rat cerebral cortical calcium-independent and calcium-dependent phosphodiesterases in crude extracts using deoxycyclic AMP and potassium ions. , 1984, Biochimica et biophysica acta.

[18]  M. Brezinski,et al.  Stereospecific binding of the antidepressant rolipram to brain protein structures. , 1986, European journal of pharmacology.

[19]  M. Kuhar,et al.  Distribution of α2 agonist binding sites in the rat and human central nervous system: Analysis of some functional, anatomic correlates of the pharmacologic effects of clonidine and related adrenergic agents , 1984, Brain Research Reviews.

[20]  M. T. Shipley,et al.  The indusium griseum in the mouse: Architecture, Timm's histochemistry and some afferent connections , 1984, Brain Research Bulletin.

[21]  R. Ebstein,et al.  The cyclic AMP second messenger system in man: The effects of heredity, hormones, drugs, aluminum, age and disease on signal amplification , 1986, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[22]  R. Horowski,et al.  Clinical effects of the neurotropic selective cAMP phosphodiesterase inhibitor rolipram in depressed patients: global evaluation of the preliminary reports , 1985 .

[23]  R. Dirksen,et al.  Dipropylacetate-induced shaking behaviour in the rat: a role of spinal α2-adrenoceptors , 1988 .

[24]  T Hoshi,et al.  Effect of forskolin on voltage-gated K+ channels is independent of adenylate cyclase activation. , 1988, Science.

[25]  L. Squire,et al.  Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[26]  S. Snyder.  Brain receptors: the emergence of a new pharmacology , 1986, Trends in Neurosciences.

[27]  A. Lewandowska,et al.  The Influence of Rolipram on the Central Serotoninergic System , 1981, Pharmacopsychiatria.

[28]  C. Balaban,et al.  Differential localization of calmodulin-dependent enzymes in rat brain: evidence for selective expression of cyclic nucleotide phosphodiesterase in specific neurons. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Michael J. Kuhar,et al.  A new method for receptor autoradiography: [3H]Opioid receptors in rat brain , 1979, Brain Research.

[30]  J. Kehne,et al.  The role of spinal cord cyclic AMP in the acoustic startle response in rats , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[31]  K. Tyler.  Host and viral factors that influence viral neurotropism I. Viral cell attachment proteins and target cell receptors , 1987, Trends in Neurosciences.

[32]  P. Löschmann,et al.  Effects of forskolin on spontaneous behavior, rectal temperature and brain cAMP levels of rats: interaction with rolipram , 1987, Neuroscience Letters.

[33]  C. Yamamoto,et al.  EFFECT OF STIMULATION OF EXCITATORY NERVE TRACT ON RELEASE OF GLUTAMIC ACID FROM OLFACTORY CORTEX SLICES IN VITRO , 1976, Journal of neurochemistry.

[34]  H. Collier,et al.  Morphine abstinence is associated with increased brain cyclic AMP , 1975, Nature.

[35]  B. Parsons,et al.  High-affinity binding sites for [3H]MPTP may correspond to monamine oxidase. , 1984, European journal of pharmacology.

[36]  P. Löschmann,et al.  Absence of anticholinergic activity of rolipram, an antidepressant with a novel mechanism of action, in three different animal models in vivo. , 1988, Pharmacopsychiatry.

[37]  H. Wachtel,et al.  Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors , 1983, Neuropharmacology.

[38]  F. Fonnum,et al.  Regional cortical glutamergic and aspartergic projections to the amygdala and thalamus of the rat , 1983, Brain Research.

[39]  B. Parsons,et al.  Quantitative autoradiography of beta 1- and beta 2-adrenergic receptors in rat brain. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Y. Nishizuka,et al.  Distribution of protein kinase C-like immunoreactive neurons in rat brain , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[41]  J. Fastbom,et al.  The distribution of adenosine a1 receptors and 5'-nucleotidase in the brain of some commonly used experimental animals , 1987, Neuroscience.

[42]  S. Snyder,et al.  Mapping second messenger systems in the brain: differential localizations of adenylate cyclase and protein kinase C. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[43]  G. Shepherd.  The Synaptic Organization of the Brain , 1979 .

[44]  D. Quartermain,et al.  Brain cyclic AMP and memory in mice , 1982, Pharmacology Biochemistry and Behavior.

[45]  J. Palacios,et al.  Autoradiographic visualization of A1-adenosine receptors in brain and peripheral tissues of rat and guinea pig using 125I-HPIA , 1988, Neuroscience Letters.